Familial adenomatous polyposis secondary prevention

	Familial adenomatous polyposis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Familial adenomatous polyposis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Familial adenomatous polyposis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Familial adenomatous polyposis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Familial adenomatous polyposis secondary prevention
CDC on Familial adenomatous polyposis secondary prevention
Familial adenomatous polyposis secondary prevention in the news
Blogs on Familial adenomatous polyposis secondary prevention
Directions to Hospitals Treating Familial adenomatous polyposis
Risk calculators and risk factors for Familial adenomatous polyposis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Effective measures for the secondary prevention of anastomostic polyp recurrence after ileal pouch anal anastomosis (IPAA) include:
- Pouchoscopy every year